Evaluation of SCOUT DS Device in the Diagnosis of Diabetes

NCT01634997 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 330

Last updated 2012-07-06

No results posted yet for this study

Summary

The primary objective is to identify compare SCOUT DS to random capillary glucose for identification of at-risk subjects with dysglycemia defined by hemoglobin A1c ≥ 6.0%.

Conditions

Sponsors & Collaborators

  • VeraLight, Inc.

    lead INDUSTRY

Principal Investigators

  • Richard Pope, MD · Airedale General Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01634997 on ClinicalTrials.gov